Epithelioid Sarcoma: Need for a Multimodal Approach to Maximize the Chances of Curative Conservative Treatment
- 18 September 2013
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (1) , 269-276
Abstract
This study was designed to evaluate the impact of multimodal management on a series of epithelioid sarcoma (ES) patients treated with curative intent. Data were collected on 69 consecutive patients treated from 1982 to 2012. Univariate and multivariate analyses were performed for tumor control and overall survival (OS). In total, 54 (78 %) patients had localized ES (M0 group). In the M0 group, 85 % of patients received multimodal management (surgery n = 50, radiotherapy n = 37, chemotherapy n = 30). Among 42 patients with limb ES, 9 (21 %) underwent amputation, and isolated limb perfusion (ILP) was required in 17 (40.5 %) to allow conservative management. Among the 45 patients who underwent conservative surgery, flap reconstructions were required in 13 (28.8 %). The median follow-up was 5.7 years. The 5-year actuarial OS rates were 54, 62, and 24 % in the entire group and the M0 and M1 groups, respectively. In the M0 group, the 5-year actuarial distant control, local control (LC), and locoregional control rates were 67, 75, and 66 %, respectively. Prognostic factors for poor OS in the multivariate analysis were tumors that were deep to the fascia (p = 0.04) and grade 3 (p = 0.005). In the univariate analysis, age p = 0.04), the T2 stage (p = 0.04), and mass presentation (p = 0.03) correlated with decreased LC, whereas patients who underwent ILP had a significantly higher LC rate (hazard ratio 3; 95 % confidence interval 0.9–9.4; p = 0.05). Multimodal management including ILP and flap reconstruction is necessary to achieve optimal conservative LC. High rates of metastasis and lymphatic spread require innovative systemic treatments.Keywords
This publication has 31 references indexed in Scilit:
- Isolated limb perfusion with TNF‐alpha and melphalan for distal parts of the limb in soft tissue sarcoma patientsJournal of Surgical Oncology, 2011
- Combining EGFR and mTOR Blockade for the Treatment of Epithelioid SarcomaClinical Cancer Research, 2011
- Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and EfficientAnnals of Surgical Oncology, 2009
- Epithelioid Soft Tissue TumorsSeminars in Oncology, 2009
- Epithelioid Sarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single InstitutionAnnals of Surgical Oncology, 2007
- Prospective evaluation of quality of surgery in soft tissue sarcomaEuropean Journal of Surgical Oncology, 2006
- Advanced Extremity Soft Tissue Sarcoma: Prognostic Effect of Isolated Limb Perfusion in a Series of 88 Patients Treated at a Single InstitutionAnnals of Surgical Oncology, 2006
- Epithelioid sarcoma: Still an only surgically curable diseaseCancer, 2006
- Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapyCancer, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000